-
1
-
-
34548104636
-
Diabetic peripheral neuropathic pain: Recognition and management
-
Cole BE. Diabetic peripheral neuropathic pain: recognition and management. Pain Med. 8(Suppl. 2), S27-S32 (2007).
-
(2007)
Pain Med
, vol.8
, Issue.SUPPL. 2
-
-
Cole, B.E.1
-
2
-
-
34548144817
-
Diabetic peripheral neuropathic pain. Consensus guidelines for treatment
-
Diabetic peripheral neuropathic pain. Consensus guidelines for treatment. J. Fam. Pract. (Suppl.) 3-19 (2006).
-
(2006)
J. Fam. Pract
, Issue.SUPPL.
, pp. 3-19
-
-
-
3
-
-
20144389536
-
Diabetic neuropathies: A statement by the American Diabetes Association
-
Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28(4), 956-962 (2005).
-
(2005)
Diabetes Care
, vol.28
, Issue.4
, pp. 956-962
-
-
Boulton, A.J.1
Vinik, A.I.2
Arezzo, J.C.3
-
4
-
-
0033988613
-
Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life
-
Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res. Clin. Pract. 47(2), 123-128 (2000).
-
(2000)
Diabetes Res. Clin. Pract
, vol.47
, Issue.2
, pp. 123-128
-
-
Galer, B.S.1
Gianas, A.2
Jensen, M.P.3
-
5
-
-
55849131161
-
duloxetine hydrochloride) delayed-release capsules prescribing information. Eli Lilly and Company
-
Indianapolis, USA 2007
-
Cymbalta® (duloxetine hydrochloride) delayed-release capsules prescribing information. Eli Lilly and Company, Indianapolis, IN, USA (2007).
-
-
-
Cymbalta®1
-
6
-
-
55849131927
-
pregabalin) prescribing information. Pfizer Inc
-
New York, NY, USA 2007
-
Lyrica® (pregabalin) prescribing information. Pfizer Inc. New York, NY, USA (2007).
-
-
-
Lyrica®1
-
7
-
-
33750048137
-
EFNS guidelines on pharmacological treatment of neuropathic pain
-
Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur. J. Neurol. 13(11), 1153-1169 (2006).
-
(2006)
Eur. J. Neurol
, vol.13
, Issue.11
, pp. 1153-1169
-
-
Attal, N.1
Cruccu, G.2
Haanpaa, M.3
-
8
-
-
0345445898
-
Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations
-
Dworkin RH, Backonja M, Rowbotham MC et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60(11), 1524-1534 (2003).
-
(2003)
Arch. Neurol
, vol.60
, Issue.11
, pp. 1524-1534
-
-
Dworkin, R.H.1
Backonja, M.2
Rowbotham, M.C.3
-
9
-
-
34248591500
-
Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society
-
Moulin DE, Clark AJ, Gilron I et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res. Manag. 12(1), 13-21 (2007).
-
(2007)
Pain Res. Manag
, vol.12
, Issue.1
, pp. 13-21
-
-
Moulin, D.E.1
Clark, A.J.2
Gilron, I.3
-
10
-
-
35748943212
-
Pharmacologic management of neuropathic pain: Evidence-based recommendations
-
Provides evidence-based recommendations for the treatment of neuropathic pain, •
-
Dworkin RH, O'Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132(3), 237-251 (2007). • Provides evidence-based recommendations for the treatment of neuropathic pain.
-
(2007)
Pain
, vol.132
, Issue.3
, pp. 237-251
-
-
Dworkin, R.H.1
O'Connor, A.B.2
Backonja, M.3
-
11
-
-
33645689140
-
Consensus guidelines: Treatment planning and options. Diabetic peripheral neuropathic pain
-
Includes guidelines from the DPNP Consensus Treatment Guidelines Advisory Board for the treatment of diabetic peripheral neuropathic pain, •
-
Argoff CE, Backonja MM, Belgrade MJ et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin. Proc. 81(4 Suppl.), S12-S25 (2006). • Includes guidelines from the DPNP Consensus Treatment Guidelines Advisory Board for the treatment of diabetic peripheral neuropathic pain.
-
(2006)
Mayo Clin. Proc
, vol.81
, Issue.4 SUPPL.
-
-
Argoff, C.E.1
Backonja, M.M.2
Belgrade, M.J.3
-
12
-
-
0029898015
-
Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives
-
Choi D, Stables JP, Kohn H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives. J. Med. Chem. 39(9), 1907-1916 (1996).
-
(1996)
J. Med. Chem
, vol.39
, Issue.9
, pp. 1907-1916
-
-
Choi, D.1
Stables, J.P.2
Kohn, H.3
-
13
-
-
34247855780
-
Lacosamide: A review of preclinical properties
-
Reviews the two proposed mechanisms of action of lacosamide and the efficacy of lacosamide in preclinical neuropathic pain models, ••
-
Beyreuther BK, Freitag J, Heers C, Krebsfanger N, Scharfenecker U, Stohr T. Lacosamide: a review of preclinical properties. CNS Drug. Rev. 13(1), 21-42 (2007). •• Reviews the two proposed mechanisms of action of lacosamide and the efficacy of lacosamide in preclinical neuropathic pain models.
-
(2007)
CNS Drug. Rev
, vol.13
, Issue.1
, pp. 21-42
-
-
Beyreuther, B.K.1
Freitag, J.2
Heers, C.3
Krebsfanger, N.4
Scharfenecker, U.5
Stohr, T.6
-
14
-
-
37349071555
-
The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels
-
Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels, ••
-
Errington AC, Stohr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol. Pharmacol. 73(1), 157-169 (2008). •• Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels.
-
(2008)
Mol. Pharmacol
, vol.73
, Issue.1
, pp. 157-169
-
-
Errington, A.C.1
Stohr, T.2
Heers, C.3
Lees, G.4
-
15
-
-
45749155596
-
Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N- benzyl-3-methoxypropanamide], lidocaine, and carbamazepine
-
Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels, ••
-
Sheets PL, Heers C, Stoehr T, Cummins TR. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N- benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J. Pharmacol. Exp. Ther. 326(1), 89-99 (2008). •• Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels.
-
(2008)
J. Pharmacol. Exp. Ther
, vol.326
, Issue.1
, pp. 89-99
-
-
Sheets, P.L.1
Heers, C.2
Stoehr, T.3
Cummins, T.R.4
-
16
-
-
34248183553
-
Proteome changes associated with hippocampal MRI abnormalities in the lithium pilocarpine-induced model of convulsive status epilepticus
-
Greene ND, Bamidele A, Choy M et al. Proteome changes associated with hippocampal MRI abnormalities in the lithium pilocarpine-induced model of convulsive status epilepticus. Proteomics 7(8), 1336-1344 (2007).
-
(2007)
Proteomics
, vol.7
, Issue.8
, pp. 1336-1344
-
-
Greene, N.D.1
Bamidele, A.2
Choy, M.3
-
17
-
-
39749159026
-
Proteomic analysis of stargazer mutant mouse neuronal proteins involved in absence seizure
-
Ryu MJ, Lee C, Kim J, Shin HS, Yu MH. Proteomic analysis of stargazer mutant mouse neuronal proteins involved in absence seizure. J. Neurochem. 104(5), 1260-1270 (2008).
-
(2008)
J. Neurochem
, vol.104
, Issue.5
, pp. 1260-1270
-
-
Ryu, M.J.1
Lee, C.2
Kim, J.3
Shin, H.S.4
Yu, M.H.5
-
18
-
-
33845225373
-
Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia
-
Katano T, Mabuchi T, Okuda-Ashitaka E, Inagaki N, Kinumi T, Ito S. Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. Proteomics 6(22), 6085-6094 (2006).
-
(2006)
Proteomics
, vol.6
, Issue.22
, pp. 6085-6094
-
-
Katano, T.1
Mabuchi, T.2
Okuda-Ashitaka, E.3
Inagaki, N.4
Kinumi, T.5
Ito, S.6
-
19
-
-
11144259374
-
Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy
-
Czech T, Yang JW, Csaszar E, Kappler J, Baumgartner C, Lubec G. Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy. Neurochem. Res. 29(12), 2189-2196 (2004).
-
(2004)
Neurochem. Res
, vol.29
, Issue.12
, pp. 2189-2196
-
-
Czech, T.1
Yang, J.W.2
Csaszar, E.3
Kappler, J.4
Baumgartner, C.5
Lubec, G.6
-
20
-
-
0002731330
-
Propagated signaling: The action potential
-
4th Edition, Kandel ER, Schwartz JH, Jessell TM Eds, McGraw-Hill, New York, NY, USA
-
Koester J, Siegelbaum SA. Propagated signaling: the action potential. In: Principles of Neural Science (4th Edition). Kandel ER, Schwartz JH, Jessell TM (Eds). McGraw-Hill, New York, NY, USA 150-170 (2000).
-
(2000)
Principles of Neural Science
, pp. 150-170
-
-
Koester, J.1
Siegelbaum, S.A.2
-
21
-
-
55849091123
-
Lacosamide modulates collapsin response mediator protein 2 (CRMP-2) (Abstract)
-
Freitag J, Beyreuther B, Heers C, Stohr T. Lacosamide modulates collapsin response mediator protein 2 (CRMP-2) (Abstract). Neurology 68(12 Suppl. 1), A125 (2007).
-
(2007)
Neurology
, vol.68
, Issue.12 SUPPL. 1
-
-
Freitag, J.1
Beyreuther, B.2
Heers, C.3
Stohr, T.4
-
22
-
-
32844470254
-
Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain
-
Stöhr T, Krause E, Selve N. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain. Eur. J. Pain. 10(3), 241-249 (2006).
-
(2006)
Eur. J. Pain
, vol.10
, Issue.3
, pp. 241-249
-
-
Stöhr, T.1
Krause, E.2
Selve, N.3
-
23
-
-
33646882590
-
Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy
-
Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur. J. Pharmacol. 539(1-2), 64-70 (2006).
-
(2006)
Eur. J. Pharmacol
, vol.539
, Issue.1-2
, pp. 64-70
-
-
Beyreuther, B.1
Callizot, N.2
Stohr, T.3
-
24
-
-
55849094455
-
Lacosamide displays potent antinociceptive effects in animal models for neuropathic pain and inflammatory pain
-
Presented at:, Sydney, Australia, 21-26 August
-
Stöhr TBB, Selve N. Lacosamide displays potent antinociceptive effects in animal models for neuropathic pain and inflammatory pain. Presented at: 11th World Congress on Pain. Sydney, Australia, 21-26 August 2005.
-
(2005)
11th World Congress on Pain
-
-
Stöhr, T.B.B.1
Selve, N.2
-
25
-
-
34249035783
-
Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain
-
Beyreuther BK, Callizot N, Brot MD, Feldman R, Bain SC, Stohr T. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur. J. Pharmacol. 565(1-3), 98-104 (2007).
-
(2007)
Eur. J. Pharmacol
, vol.565
, Issue.1-3
, pp. 98-104
-
-
Beyreuther, B.K.1
Callizot, N.2
Brot, M.D.3
Feldman, R.4
Bain, S.C.5
Stohr, T.6
-
26
-
-
33751170209
-
-
Hao JX, Stohr T, Selve N, Wiesenfeld-Hallin Z, Xu XJ. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Eur. J. Pharmacol. 553(1-3), 135-140 (2006).
-
Hao JX, Stohr T, Selve N, Wiesenfeld-Hallin Z, Xu XJ. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Eur. J. Pharmacol. 553(1-3), 135-140 (2006).
-
-
-
-
27
-
-
33847410500
-
Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain
-
Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthritis Res. Ther. 9(1), R14 (2007).
-
(2007)
Arthritis Res. Ther
, vol.9
, Issue.1
-
-
Beyreuther, B.1
Callizot, N.2
Stohr, T.3
-
28
-
-
34047177848
-
Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF
-
Beyreuther BK, Geis C, Stohr T, Sommer C. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology 52(5), 1312-1317 (2007).
-
(2007)
Neuropharmacology
, vol.52
, Issue.5
, pp. 1312-1317
-
-
Beyreuther, B.K.1
Geis, C.2
Stohr, T.3
Sommer, C.4
-
29
-
-
40849086321
-
Lacosamide: An investigational drug for adjunctive treatment of partial-onset seizures
-
Ben-Menachem E. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures. Drugs Today (Barc.) 44(1), 35-40 (2008).
-
(2008)
Drugs Today (Barc.)
, vol.44
, Issue.1
, pp. 35-40
-
-
Ben-Menachem, E.1
-
30
-
-
0036752811
-
Progress report on new antiepileptic drugs: A summary of the Sixth Eilat Conference (EILAT VI)
-
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E. Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res. 51(1-2), 31-71 (2002).
-
(2002)
Epilepsy Res
, vol.51
, Issue.1-2
, pp. 31-71
-
-
Bialer, M.1
Johannessen, S.I.2
Kupferberg, H.J.3
Levy, R.H.4
Loiseau, P.5
Perucca, E.6
-
31
-
-
11144232600
-
Basic clinical pharmacologic investigations of the new antiepileptic drug SPM 927 (Abstract)
-
Horstmann R, Bonn R, Cawello W, Doty P, Rudd GD. Basic clinical pharmacologic investigations of the new antiepileptic drug SPM 927 (Abstract). Epilepsia 43(Suppl. 7), 188 (2002).
-
(2002)
Epilepsia
, vol.43
, Issue.SUPPL. 7
, pp. 188
-
-
Horstmann, R.1
Bonn, R.2
Cawello, W.3
Doty, P.4
Rudd, G.D.5
-
32
-
-
33846194013
-
-
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res. 73(1), 1-52 (2007).
-
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res. 73(1), 1-52 (2007).
-
-
-
-
33
-
-
4644301804
-
-
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res. 61(1-3), 1-48 (2004).
-
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res. 61(1-3), 1-48 (2004).
-
-
-
-
34
-
-
55849142701
-
Lacosamide has low potential for drug-drug interaction
-
Presented at:, Washington, DC, USA, May 2-5
-
Thomas D, Scharfenecker U, Nickel B et al. Lacosamide has low potential for drug-drug interaction. Presented at: American Pain Society 26th Annual Scientific Meeting. Washington, DC, USA, May 2-5 2007.
-
(2007)
American Pain Society 26th Annual Scientific Meeting
-
-
Thomas, D.1
Scharfenecker, U.2
Nickel, B.3
-
35
-
-
33846234734
-
-
Doty P, Rudd GD, Stoehr T, Thomas D. Lacosamide. Neurotherapeutics 4(1), 145-148 (2007).
-
(2007)
Neurotherapeutics
, vol.4
, Issue.1
, pp. 145-148
-
-
Doty, P.1
Rudd, G.D.2
Stoehr, T.3
Lacosamide, T.D.4
-
36
-
-
55849125190
-
Low potential for drug-drug-interaction of lacosamide (Abstract)
-
S
-
Thomas D, Scharfenecker U, Schiltmeyer B, Cawello W, Doty P, Horstmann R. Low potential for drug-drug-interaction of lacosamide (Abstract). J. Pain 8(4 Suppl. 1), S39 (2007).
-
(2007)
J. Pain
, vol.8
, Issue.4 SUPPL. 1
, pp. 39
-
-
Thomas, D.1
Scharfenecker, U.2
Schiltmeyer, B.3
Cawello, W.4
Doty, P.5
Horstmann, R.6
-
37
-
-
33846244930
-
Pharmacokinetics of the new antiepileptic drug SPM 927 in human subjects with different age and gender (Abstract)
-
Schiltmeyer B, Cawello W, Kropeit D, Hammes W, Hortsmann R. Pharmacokinetics of the new antiepileptic drug SPM 927 in human subjects with different age and gender (Abstract). Epilepsia 46(Suppl. 7), 313 (2004).
-
(2004)
Epilepsia
, vol.46
, Issue.SUPPL. 7
, pp. 313
-
-
Schiltmeyer, B.1
Cawello, W.2
Kropeit, D.3
Hammes, W.4
Hortsmann, R.5
-
38
-
-
33846242456
-
Food does not affect the pharmacokinetics of SPM 927
-
Cawello W, Kropeit D, Schiltmeyer B, Hammes W, Horstmann R. Food does not affect the pharmacokinetics of SPM 927. Epilepsia 45(Suppl. 7), 307 (2004).
-
(2004)
Epilepsia
, vol.45
, Issue.SUPPL. 7
, pp. 307
-
-
Cawello, W.1
Kropeit, D.2
Schiltmeyer, B.3
Hammes, W.4
Horstmann, R.5
-
39
-
-
11144223136
-
Absence of effect of adjunctive SPM 927 on concomitant AED plasma concentrations in subjects with partial seizures
-
Fountain NB, Horstmann R, Cawello W, Doty P, Rudd GD. Absence of effect of adjunctive SPM 927 on concomitant AED plasma concentrations in subjects with partial seizures. Epilepsia 44(Suppl. 9), 96 (2003).
-
(2003)
Epilepsia
, vol.44
, Issue.SUPPL. 9
, pp. 96
-
-
Fountain, N.B.1
Horstmann, R.2
Cawello, W.3
Doty, P.4
Rudd, G.D.5
-
40
-
-
11144238504
-
SPM 927 does not interact with valproic acid and carbamazepine (Abstract)
-
Horstmann R, Bonn R, Cawello W, Doty P, Rudd GD. SPM 927 does not interact with valproic acid and carbamazepine (Abstract). Epilepsia 44(Suppl. 9), 97 (2003).
-
(2003)
Epilepsia
, vol.44
, Issue.SUPPL. 9
, pp. 97
-
-
Horstmann, R.1
Bonn, R.2
Cawello, W.3
Doty, P.4
Rudd, G.D.5
-
41
-
-
33846258011
-
Evaluation of the effect of oral lacosamide on concomitant AED plasma concentrations in patients with partial seizures (Abstract)
-
Jatuzis D, Biton V, Ben-Menachem E, Abou-Khalil B, Doty P, Rudd GD. Evaluation of the effect of oral lacosamide on concomitant AED plasma concentrations in patients with partial seizures (Abstract). Epilepsia 46(Suppl. 8), 170 (2005).
-
(2005)
Epilepsia
, vol.46
, Issue.SUPPL. 8
, pp. 170
-
-
Jatuzis, D.1
Biton, V.2
Ben-Menachem, E.3
Abou-Khalil, B.4
Doty, P.5
Rudd, G.D.6
-
42
-
-
55849112745
-
Lacosamide does not interact with valproic acid and carbamazepine
-
Presented at:, Boston, MA, 5-10 December
-
Horstmann R, Bonn R, Cawello W, Doty P, Rudd D. Lacosamide does not interact with valproic acid and carbamazepine. Presented at: American Epilepsy Society 57th Annual Meeting. Boston, MA, 5-10 December 2003.
-
(2003)
American Epilepsy Society 57th Annual Meeting
-
-
Horstmann, R.1
Bonn, R.2
Cawello, W.3
Doty, P.4
Rudd, D.5
-
43
-
-
39749167069
-
Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures
-
Multicenter, double-blind, doubledummy, randomized trial of intravenous lacosamide as a replacement for oral lacosamide in patients with partial-onset seizures, •
-
Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 49(3), 418-424 (2008). • Multicenter, double-blind, doubledummy, randomized trial of intravenous lacosamide as a replacement for oral lacosamide in patients with partial-onset seizures.
-
(2008)
Epilepsia
, vol.49
, Issue.3
, pp. 418-424
-
-
Biton, V.1
Rosenfeld, W.E.2
Whitesides, J.3
Fountain, N.B.4
Vaiciene, N.5
Rudd, G.D.6
-
44
-
-
55849095223
-
Pharmacokinetics and safety of intravenous lacosamide administered as replacement for adjunctive oral lacosamide in patients with partial-onset seizures (Abstract)
-
Rosenfeld WE, Biton V, Mameniskiene R et al. Pharmacokinetics and safety of intravenous lacosamide administered as replacement for adjunctive oral lacosamide in patients with partial-onset seizures (Abstract). Epilepsia 46(Suppl. 8), 184 (2005).
-
(2005)
Epilepsia
, vol.46
, Issue.SUPPL. 8
, pp. 184
-
-
Rosenfeld, W.E.1
Biton, V.2
Mameniskiene, R.3
-
45
-
-
0242558798
-
Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study
-
McCleane G, Koch B, Rauschkolb C. Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study. Neurosci. Lett. 352(2), 117-120 (2003).
-
(2003)
Neurosci. Lett
, vol.352
, Issue.2
, pp. 117-120
-
-
McCleane, G.1
Koch, B.2
Rauschkolb, C.3
-
46
-
-
33846477913
-
A report of the continuing analgesia after 12 months treatment with SPM 927 in six subjects with neuropathic pain
-
McCleane GJ, Koch B, Rauschkolb C. A report of the continuing analgesia after 12 months treatment with SPM 927 in six subjects with neuropathic pain. J. Neuropathic Pain Symptom Palliation 1(1), 25-28 (2005).
-
(2005)
J. Neuropathic Pain Symptom Palliation
, vol.1
, Issue.1
, pp. 25-28
-
-
McCleane, G.J.1
Koch, B.2
Rauschkolb, C.3
-
47
-
-
33846535387
-
-
Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a Phase 2 double-blind placebo-controlled study. Clin. J. Pain 23(2), 150-158 (2007). • Phase II multicenter, randomized, double-blind, placebo-controlled trial of lacosamide in diabetic neuropathic pain.
-
Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a Phase 2 double-blind placebo-controlled study. Clin. J. Pain 23(2), 150-158 (2007). • Phase II multicenter, randomized, double-blind, placebo-controlled trial of lacosamide in diabetic neuropathic pain.
-
-
-
-
48
-
-
0034748159
-
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
-
Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2), 149-158 (2001).
-
(2001)
Pain
, vol.94
, Issue.2
, pp. 149-158
-
-
Farrar, J.T.1
Young Jr, J.P.2
LaMoreaux, L.3
Werth, J.L.4
Poole, R.M.5
-
49
-
-
0037406025
-
Clinically important changes in acute pain outcome measures: A validation study
-
Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J. Pain Symptom Manage. 25(5), 406-411 (2003).
-
(2003)
J. Pain Symptom Manage
, vol.25
, Issue.5
, pp. 406-411
-
-
Farrar, J.T.1
Berlin, J.A.2
Strom, B.L.3
-
50
-
-
55849134569
-
A multicenter, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742) (Abstract)
-
S
-
Wymer J. A multicenter, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742) (Abstract). Ann. Neurol. 60(Suppl. 11), S68 (2006).
-
(2006)
Ann. Neurol
, vol.60
, Issue.SUPPL. 11
, pp. 68
-
-
Wymer, J.1
-
51
-
-
55849104432
-
Efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742)
-
Presented at:, Colorado Springs, CO, USA, 15-18 April
-
Wymer J. Efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742). Presented at: College of Psychiatric and Neurologic Pharmacists 10th Annual Meeting. Colorado Springs, CO, USA, 15-18 April 2007.
-
(2007)
College of Psychiatric and Neurologic Pharmacists 10th Annual Meeting
-
-
Wymer, J.1
-
52
-
-
55849148154
-
A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide in subjects with painful distal diabetic neuropathy (SP743)
-
Presented at:, Sydney, Australia, 21-26 August
-
Ziegler D, Bongardt S, Thierfelder S, Koch B. A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide in subjects with painful distal diabetic neuropathy (SP743). Presented at: 11th World Congress on Pain. Sydney, Australia, 21-26 August 2005.
-
(2005)
11th World Congress on Pain
-
-
Ziegler, D.1
Bongardt, S.2
Thierfelder, S.3
Koch, B.4
-
53
-
-
55849092622
-
-
Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in painful distal diabetic neuropathy: results of a multi-center, placebo-controlled US trial (SP768) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 250 (2007).
-
Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in painful distal diabetic neuropathy: results of a multi-center, placebo-controlled US trial (SP768) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 250 (2007).
-
-
-
-
54
-
-
55849146771
-
-
Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, randomized, double-blind, placebo-controlled, parallel group trial (SP768). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
-
Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, randomized, double-blind, placebo-controlled, parallel group trial (SP768). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
-
-
-
-
55
-
-
55849152889
-
Evaluation of lacosamide in diabetic neuropathic pain trials
-
Presented at:, Tampa, FL, USA, 8-10 May
-
Shaibani A, Bongardt S, Sommerville K, Simpson J. Evaluation of lacosamide in diabetic neuropathic pain trials. Presented at: American Pain Society 27th Annual Scientific Meeting. Tampa, FL, USA, 8-10 May 2008.
-
(2008)
American Pain Society 27th Annual Scientific Meeting
-
-
Shaibani, A.1
Bongardt, S.2
Sommerville, K.3
Simpson, J.4
-
56
-
-
55849103286
-
-
UCB. Data presented at AAN show that lacosamide significantly reduced pain and was generally well tolerated in patients with diabetic neuropathic pain (media release) April 16 2008.
-
UCB. Data presented at AAN show that lacosamide significantly reduced pain and was generally well tolerated in patients with diabetic neuropathic pain (media release) April 16 2008.
-
-
-
-
57
-
-
55849115752
-
Evaluation of lacosamide in diabetic neuropathic pain trials (Abstract)
-
Shaibani A, Bongardt S, Sommerville K. Evaluation of lacosamide in diabetic neuropathic pain trials (Abstract). J. Pain 9(4), 21 (2008).
-
(2008)
J. Pain
, vol.9
, Issue.4
, pp. 21
-
-
Shaibani, A.1
Bongardt, S.2
Sommerville, K.3
-
58
-
-
55849087722
-
-
Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials. Presented at: The American Academy of Neurology 60th Annual Meeting. Chicago, IL, USA, 12-19 April 2008.
-
Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials. Presented at: The American Academy of Neurology 60th Annual Meeting. Chicago, IL, USA, 12-19 April 2008.
-
-
-
-
59
-
-
55849132301
-
-
Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with diabetic neuropathic pain: a summary of adverse events in four double-blind randomized clinical trials. Presented at: American Diabetes Association 68th Annual Meeting. San Francisco, CA, USA, 6-10 June 2008.
-
Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with diabetic neuropathic pain: a summary of adverse events in four double-blind randomized clinical trials. Presented at: American Diabetes Association 68th Annual Meeting. San Francisco, CA, USA, 6-10 June 2008.
-
-
-
-
60
-
-
55849111283
-
Safety summary of lacosamide for treatment of diabetic neuropathic pain (Abstract)
-
Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Safety summary of lacosamide for treatment of diabetic neuropathic pain (Abstract). Diabetes 57(Suppl. 1), A158 (2008).
-
(2008)
Diabetes
, vol.57
, Issue.SUPPL. 1
-
-
Wymer, J.1
Ziegler, D.2
Sommerville, K.3
Bongardt, S.4
Shaibani, A.5
-
61
-
-
55849118203
-
-
Wymer J, Ziegler D, Sommerville K, Bongardt S. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials (Abstract). Neurology 70(Suppl. 1), A163 (2008).
-
Wymer J, Ziegler D, Sommerville K, Bongardt S. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials (Abstract). Neurology 70(Suppl. 1), A163 (2008).
-
-
-
-
62
-
-
55849148553
-
Lacosamide demonstrates no potential for QTc-prolongation
-
Presented at:, Southampton, Bermuda, 2-4 November
-
Thomas D, Zisowsky J, Wilhelm D, Horstmann R. Lacosamide demonstrates no potential for QTc-prolongation. Presented at: 9th International Conference on the Mechanisms and Treatment of Neuropathic Pain. Southampton, Bermuda, 2-4 November 2006.
-
(2006)
9th International Conference on the Mechanisms and Treatment of Neuropathic Pain
-
-
Thomas, D.1
Zisowsky, J.2
Wilhelm, D.3
Horstmann, R.4
-
63
-
-
55849090763
-
Long-term efficacy of lacosamide in subjects with diabetic neuropathic pain: Results of a double-blind, randomized withdrawal trial (SP746-1) (Abstract)
-
Hidvégi T, Bretschneider M, Thierfelder S, Sommerville K, Bongardt S. Long-term efficacy of lacosamide in subjects with diabetic neuropathic pain: results of a double-blind, randomized withdrawal trial (SP746-1) (Abstract). J. Pain 9(4), 27 (2008).
-
(2008)
J. Pain
, vol.9
, Issue.4
, pp. 27
-
-
Hidvégi, T.1
Bretschneider, M.2
Thierfelder, S.3
Sommerville, K.4
Bongardt, S.5
-
64
-
-
55849115753
-
Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial
-
Epub ahead of print, •• Long-term, multicenter, open-label extension trial of lacosamide in diabetic neuropathic pain
-
Shaibani A, Biton V, Rauck R, Koch B, Simpson J. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur. J. Pain. (2008) (Epub ahead of print). •• Long-term, multicenter, open-label extension trial of lacosamide in diabetic neuropathic pain.
-
(2008)
Eur. J. Pain
-
-
Shaibani, A.1
Biton, V.2
Rauck, R.3
Koch, B.4
Simpson, J.5
-
65
-
-
55849114174
-
-
Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (SP745). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
-
Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (SP745). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
-
-
-
-
66
-
-
55849111284
-
-
Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (DNP) (SP745) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 260 (2007).
-
Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (DNP) (SP745) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 260 (2007).
-
-
-
-
67
-
-
55849089329
-
-
Hidvégi T, Bretschneider M, Bongardt S, Koch B. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, open-label, follow-on trial (SP746). Presented at: American Pain Society 25th Annual Scientific Meeting. San Antonio, TX, USA, 3-6 May 2006.
-
Hidvégi T, Bretschneider M, Bongardt S, Koch B. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, open-label, follow-on trial (SP746). Presented at: American Pain Society 25th Annual Scientific Meeting. San Antonio, TX, USA, 3-6 May 2006.
-
-
-
-
68
-
-
55849142016
-
A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy (SP746) (Abstract)
-
S
-
Bretschneider M, Bongardt S, Koch B. A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy (SP746) (Abstract). J. Pain 7(4), S43 (2006).
-
(2006)
J. Pain
, vol.7
, Issue.4
, pp. 43
-
-
Bretschneider, M.1
Bongardt, S.2
Koch, B.3
-
69
-
-
55849126802
-
-
Simpson K, Tzschaschel B, Bongardt S, Koch B. Lacosamide in patients with painful diabetic neuropathy: one year interim results from a long-term, multicenter, open-label trial (SP830). Presented at: Pain in Europe Congress. Istanbul, Turkey, 13-16 September 2006.
-
Simpson K, Tzschaschel B, Bongardt S, Koch B. Lacosamide in patients with painful diabetic neuropathy: one year interim results from a long-term, multicenter, open-label trial (SP830). Presented at: Pain in Europe Congress. Istanbul, Turkey, 13-16 September 2006.
-
-
-
-
70
-
-
0030443813
-
A systematic review of antidepressants in neuropathic pain
-
McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 68(2-3), 217-227 (1996).
-
(1996)
Pain
, vol.68
, Issue.2-3
, pp. 217-227
-
-
McQuay, H.J.1
Tramer, M.2
Nye, B.A.3
Carroll, D.4
Wiffen, P.J.5
Moore, R.A.6
-
71
-
-
0032477332
-
Symptomatic treatment of painful neuropathy
-
Low PA, Dotson RM. Symptomatic treatment of painful neuropathy. JAMA 280(21), 1863-1864 (1998).
-
(1998)
JAMA
, vol.280
, Issue.21
, pp. 1863-1864
-
-
Low, P.A.1
Dotson, R.M.2
-
72
-
-
52449093262
-
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies
-
Deiderich NJ, Goetz CG. The placebo treatments in neurosciences: new insights from clinical and neuroimaging studies. Neurology 71(9), 677-684 (2008).
-
(2008)
Neurology
, vol.71
, Issue.9
, pp. 677-684
-
-
Deiderich, N.J.1
Goetz, C.G.2
-
73
-
-
0034328085
-
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group
-
Apfel SC, Schwartz S, Adornato BT et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284(17), 2215-2221 (2000).
-
(2000)
JAMA
, vol.284
, Issue.17
, pp. 2215-2221
-
-
Apfel, S.C.1
Schwartz, S.2
Adornato, B.T.3
-
74
-
-
34447344551
-
Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures
-
Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48(7), 1308-1317 (2007).
-
(2007)
Epilepsia
, vol.48
, Issue.7
, pp. 1308-1317
-
-
Ben-Menachem, E.1
Biton, V.2
Jatuzis, D.3
Abou-Khalil, B.4
Doty, P.5
Rudd, G.D.6
-
75
-
-
51449124170
-
Lacosamide: Efficacy and safety as oral adjunctive treatment for partial-onset seizures (SP754) (abstract)
-
Chung S, Sperling M, Biton V, Krauss G, Beaman M, Hebert D. Lacosamide: efficacy and safety as oral adjunctive treatment for partial-onset seizures (SP754) (abstract). Epilepsia 48(Suppl. 6), 321 (2007).
-
(2007)
Epilepsia
, vol.48
, Issue.SUPPL. 6
, pp. 321
-
-
Chung, S.1
Sperling, M.2
Biton, V.3
Krauss, G.4
Beaman, M.5
Hebert, D.6
-
76
-
-
33846220582
-
Lacosamide: Efficacy and safety as oral adjunctive therapy in adults with partial seizures (SP755) (Abstract)
-
Halász P, Kälviäinen R, Mazurkiewicz-Beldzinska M, Rosenow F, Doty P, Sullivan T. Lacosamide: efficacy and safety as oral adjunctive therapy in adults with partial seizures (SP755) (Abstract). Epilepsia 47(Suppl. 4), 3 (2006).
-
(2006)
Epilepsia
, vol.47
, Issue.SUPPL. 4
, pp. 3
-
-
Halász, P.1
Kälviäinen, R.2
Mazurkiewicz-Beldzinska, M.3
Rosenow, F.4
Doty, P.5
Sullivan, T.6
-
80
-
-
55849084406
-
-
UCB. UCB receives not-approvable letter from FDA for lacosamide for diabetic neuropathic pain (media release) July 29 (2008) www.ucb-group.com/news/ 3572.asp
-
UCB. UCB receives not-approvable letter from FDA for lacosamide for diabetic neuropathic pain (media release) July 29 (2008) www.ucb-group.com/news/ 3572.asp
-
-
-
-
81
-
-
55849146407
-
-
UCB. UCB withdraws EU marketing authorization application for lacosamide in diabetic neuropathic pain (media release) September 25 (2008) www.ucb-group.com/news/3629.asp
-
UCB. UCB withdraws EU marketing authorization application for lacosamide in diabetic neuropathic pain (media release) September 25 (2008) www.ucb-group.com/news/3629.asp
-
-
-
-
84
-
-
55849091492
-
-
A multicenter, open-label trial to assess the safety and tolerability of a single intravenous loading dose of lacosamide followed by oral lacosamide maintenance as adjunctive therapy in subjects with partial-onset seizures NLM identifier: NCT00655551 www.clinicaltrials.gov/ct2/show/ NCT00655551
-
A multicenter, open-label trial to assess the safety and tolerability of a single intravenous loading dose of lacosamide followed by oral lacosamide maintenance as adjunctive therapy in subjects with partial-onset seizures NLM identifier: NCT00655551 www.clinicaltrials.gov/ct2/show/ NCT00655551
-
-
-
|